Novo Nordisk A/S NVO:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
69.61UNCH (UNCH)
Volume
7,772
Close
69.61quote price arrow up+0.39 (+0.56%)
Volume
1,303,840
52 week range
49.24 - 75.86

...

Loading . . .

KEY STATS

  • Open69.24
  • Day High69.78
  • Day Low67.92
  • Prev Close69.22
  • 52 Week High75.86
  • 52 Week High Date02/12/21
  • 52 Week Low49.24
  • 52 Week Low Date03/20/20
  • Market Cap126.172B
  • Shares Out1.813B
  • 10 Day Average Volume1.01M
  • Dividend1.47
  • Dividend Yield2.11%
  • Beta0.44
  • 1 Year % Change11.29

RATIOS/PROFITABILITY

  • EPS (TTM)2.96
  • P/E (TTM)23.54
  • Fwd P/E (NTM)0.60
  • EBITDA (MRQ)9.642B
  • ROE (MRQ)69.70%
  • Revenue (MRQ)20.441B
  • Gross Margin (MRQ)83.51%
  • Net Margin (MRQ)33.19%
  • Debt To Equity (MRQ)16.35%

EVENTS

  • Earnings Date05/05/2021
  • Ex Div Date03/26/2021
  • Div Amount0.9494
  • Split Date-
  • Split Factor-

Latest Novo Nordisk A/S News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral...
Helge Lund
Chairman
Jeppe Christiansen
Vice Chairman
Lars Fruergaard Joergensen
President
Maziar Doustdar
Chief Operating Officer
Karsten Munk Knudsen
Chief Financial Officer
Doug Langa
Executive Vice President
Address
Novo Alle 1
Bagsvaerd
2880
Denmark